RenovoRx, Inc. - Common Stock (RNXT)

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
35,991,250
Total 13F shares
1,188,008
Share change
+1,023,280
Total reported value
$2,352,000
Price per share
$1.98
Number of holders
9
Value change
+$1,994,918
Number of buys
5
Number of sells
5

Institutional Holders of RenovoRx, Inc. - Common Stock (RNXT) as of Q2 2022

As of 30 Jun 2022, RenovoRx, Inc. - Common Stock (RNXT) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,188,008 shares. The largest 9 holders included BANK OF THE WEST, COHEN LAWRENCE B, BANK OF AMERICA CORP /DE/, STIFEL FINANCIAL CORP, Cambridge Investment Research Advisors, Inc., VANGUARD GROUP INC, UBS Group AG, Tower Research Capital LLC (TRC), and MORGAN STANLEY. This page lists 9 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.